Improved estimation of overall survival and progression-free survival for state transition modeling

Aim: National Institute for Health and Care Excellence guidance (Technical Support Document 19) highlights a key challenge of state transition models (STMs) being their difficulty in achieving a satisfactory fit to the observed within-trial endpoints. Fitting poorly to data over the trial period can...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter C Wigfield (Author), Bart Heeg (Author), Mario Ouwens (Author)
Format: Book
Published: Becaris Publishing Limited, 2023-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_271a40a48d2f467f833d5ed61a5cae3c
042 |a dc 
100 1 0 |a Peter C Wigfield  |e author 
700 1 0 |a Bart Heeg  |e author 
700 1 0 |a Mario Ouwens  |e author 
245 0 0 |a Improved estimation of overall survival and progression-free survival for state transition modeling 
260 |b Becaris Publishing Limited,   |c 2023-12-01T00:00:00Z. 
500 |a 10.57264/cer-2023-0031 
500 |a 2042-6313 
520 |a Aim: National Institute for Health and Care Excellence guidance (Technical Support Document 19) highlights a key challenge of state transition models (STMs) being their difficulty in achieving a satisfactory fit to the observed within-trial endpoints. Fitting poorly to data over the trial period can then have implications for long-term extrapolations. A novel estimation approach is defined in which the predicted overall survival (OS) and progression-free survival (PFS) extrapolations from an STM are optimized to provide closer estimates of the within-trial endpoints. Materials & methods: An STM was fitted to the SQUIRE trial data in non-small-cell lung cancer (obtained from Project Data Sphere). Two methods were used: a standard approach whereby the maximum likelihood was utilized for the individual transitions and the best-fitting parametric model elected based on AIC/BIC, and a novel approach in which parameters were optimized by minimizing the area between the STM-predicted OS and PFS curves and the corresponding OS and PFS Kaplan-Meier curves. Sensitivity analyses were conducted to assess uncertainty. Results: The novel approach resulted in closer estimations to the OS and PFS Kaplan-Meier for all combinations of parametric distributions analyzed compared with the standard approach. Though the uncertainty associated with the novel approach was slightly larger, it provided better estimates to the restricted mean survival time in 10 of the 12 parametric distributions analyzed. Conclusion: A novel approach is defined which provides an alternative STM estimation method enabling improved fits to modeled endpoints, which can easily be extended to more complex model structures. 
546 |a EN 
690 |a area between curves 
690 |a markov models 
690 |a optimization 
690 |a state transition model 
690 |a Public aspects of medicine 
690 |a RA1-1270 
655 7 |a article  |2 local 
786 0 |n Journal of Comparative Effectiveness Research, Vol 13, Iss 1 (2023) 
787 0 |n https://doaj.org/toc/2042-6313 
856 4 1 |u https://doaj.org/article/271a40a48d2f467f833d5ed61a5cae3c  |z Connect to this object online.